Felice Verduyn-van Weegen

About Felice Verduyn-van Weegen

Felice Verduyn-van Weegen is a director at AgomAb Therapeutics NV.

Form D filings name Felice Verduyn-van Weegen as a director at Evommune.

Felice Verduyn-van Weegen reports to the SEC as a director or major shareholder of 2 public companies, including Evommune (EVMN).

Experience

This experience comes from SEC filings. The years are when the filings name Felice Verduyn-van Weegen in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Felice Verduyn-van Weegen works with at each company, as listed on that company's latest Form D.

Sources

1. SECEvommune, Inc. Form D, filed Jan 8, 2025
2. SECForms 3, 4 and 5 filed by Felice Verduyn-van Weegen (SEC filer 2094941)